NEXGEN LPS-FLEX MOBILE AND LPS-MOBILE BEARING KNEE SYSTEM
Zimmer, Inc. · Decision date Dec 10, 2007
What did the FDA approve?
The December 10, 2007 approval covers the Zimmer NexGen LPS-Flex Mobile and LPS-Mobile Bearing Knee System. The FDA statement lists indications for patients with severe knee pain and disability due to osteoarthritis, primary and secondary traumatic arthritis, avascular necrosis of the femoral condyle, or moderate valgus, varus, or flexion deformities. The deformities are specified as valgus/varus of 15 degrees or less and fixed flexion of 10 degrees or less.
The approval statement also says the device is intended for cemented use only. The record identifies the product code as a semi-constrained, metal/polymer, mobile bearing patellofemorotibial knee prosthesis. The database entry does not include a supplement type or supplement reason, so no additional change to an earlier PMA is described in this record.
FDA approval order statement
APPROVAL FOR THE ZIMMER NEXGEN LPS-FLEX MOBILE AND LPS-MOBILE BEARING KNEES. THESE DEVICES ARE INDICATED FOR PATIENTS WITH SEVERE KNEE PAIN AND DISABILITY DUE TO OSTEOARTHRITIS; PRIMARY AND SECONDARY TRAUMATIC ARTHRITIS; AVASCULAR NECROSIS OF THE FEMORAL CONDYLE; OR MODERATE VALGUS, VARUS, OR FLEXION DEFORMITIES (I.E., VALGUS/VARUS DEFORMITY OF <=15 DEGREES, FIXED FLEXION DEFORMITY OF <=10 DEGREES). THIS DEVICE IS INTENDED FOR CEMENTED USE ONLY.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Orthopedic
- Decision date
- Dec 10, 2007
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P060037
- Regulatory pathway
- Premarket approval application
- Applicant
- Zimmer, Inc.
- Product code
- NJL
- Decision code
- APPR
- Decision date
- Dec 10, 2007
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Prosthesis, knee, patellofemorotibial, semi-constrained, metal/polymer, mobile bearing.
- Applicant
- Zimmer, Inc.
- Product code
- NJL
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P060037 received
Application receipt date recorded by FDA.
P060037 · FDA decision
APPR
P060037/S099 · Related supplement
NexGen LPS-Flex Mobile and LPS-Mobile Bearing Knee System
P060037/S100 · Related supplement
NexGen LPS-Flex/LPS Mobile Bearing Knee System
Timeline entries are records held by MedtechLedger for P060037. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P060037
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Zimmer, Inc. | PMA supplement | Sep 24, 2026 | FDA | |
NexGen LPS-Flex/LPS Mobile Bearing Knee SystemP060037/S100 | Zimmer, Inc. | PMA supplement | Oct 16, 2026 | FDA |
Explore the linked device profile
Other records with product code NJL
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
LCS Knee SystemP830055/S378 | Depuy, Inc. | PMA supplement | Oct 27, 2026 | FDA |
| Depuy, Inc. | PMA supplement | Oct 27, 2026 | FDA | |
ATTUNE Revision Knee SystemP830055/S379 | Depuy, Inc. | PMA supplement | Oct 9, 2026 | FDA |
| Depuy, Inc. | PMA supplement | Oct 8, 2026 | FDA | |
LCS Total Knee SystemP830055/S380 | Depuy, Inc. | PMA supplement | Oct 5, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Zimmer, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- P.O. Box 708, Warsaw, IN, 46581
Sources and methodology
- Original FDA record: P060037
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



